Showing results (391-400 of 860,673) with videos related to

Sort By:
Pageof 86,068
International Journal of Environmental Research and Public Health|July 14, 2023
Cardiometabolic Risk Markers for Aboriginal and Torres Strait Islander Children and Youths: A Systematic Review of Data Quality and Population PrevalenceEamon O'Bryan, Christopher D McKay, Sandra Eades, et al.
BMJ Open|November 6, 2017
Process evaluation of a primary healthcare validation study of a culturally adapted depression screening tool for use by Aboriginal and Torres Strait Islander people: study protocolSara Farnbach, John Evans, Anne-Marie Eades, et al.
AIDS (London, England)|November 13, 2015
High rate of lymphoma among a UK cohort of adolescents with vertically acquired HIV-1 infection transitioning to adult care in the era of antiretroviral therapyChris P Eades, Sophie A Herbert, Simon G Edwards, et al.
Journal of Molecular and Cellular Cardiology|June 6, 2026
Mutation specific impairment of fatty acid and pyruvate oxidation in hypertrophic cardiomyopathy mouse modelsMukundan Ragavan, Garretty Knotts, Tilo Thottakara, et al.
Scientific Reports|February 3, 2017
Cell-free measurements of brightness of fluorescently labeled antibodiesHaiying Zhou, George Tourkakis, Dennis Shi, et al.
Australian and New Zealand Journal of Public Health|March 6, 2024
Cardiometabolic health markers among Aboriginal adolescents from the Next Generation Youth Wellbeing Cohort StudyChristopher D McKay, Lina Gubhaju, Alison J Gibberd, et al.
The Gerontologist|May 12, 2021
The Path to Eldership: Results From a Contemporary Indigenous Australian CommunityOwen Eades, Maree R Toombs, Renata Cinelli, et al.
Diabetes/Metabolism Research and Reviews|September 20, 2015
Type 2 diabetes after gestational diabetes: greater than fourfold risk among Indigenous compared with non-Indigenous Australian womenCatherine R Chamberlain, Brian Oldenburg, Alyce N Wilson, et al.
Annals of Hematology|December 10, 2016
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomibAriana Berenson, Suzie Vardanyan, Michael David, et al.
European Journal of Haematology|March 11, 2018
Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective studyZachary Gross, Ashkon Rahbari, Eric Wirtschafter, et al.
Pageof 86,068